Four out of five doses of AstraZeneca distributed in Europe have not been applied, according to The Guardian

Four out of five doses of the vaccine Oxford / AstraZeneca against the coronavirus distributed in the countries of The European Union has not yet been administered, as revealed by a survey of The Guardian.

AstraZeneca dosages suffer rejection by the population after the German, Italian, French and Polish authorities recommended the use of the vaccine in patients under 65 years of age. Different governments fail to “redirect flat tires to young people”.

The investigation showed that it remained to apply 4,849,752 doses of the 6,134,707 sent among the 27 Member States, according to data collected from the European Center for Prevention and Control (ECDC).

“There is currently an acceptance problem with the AstraZeneca vaccine,” the Chancellor said. Angela Merkel in an interview with a German media. “AstraZeneca is a reliable, effective and safe vaccine approved by the European Medicines Agency and recommended in Germany up to the age of 65. All authorities tell us that this vaccine is trustworthy. As long as vaccines are scarce like today, it will not be possible to choose which one to be vaccinated with, ”he said.

The data analyzed by the British media “highlight striking discrepancies between the quantity of AstraZeneca vaccines available in member states and their administration to the population”.

The Guardian He reported that:

“In comparison, they were administered four out of five doses of Pfizer vaccine supplied to Belgium (81%), Italy (80%) and Germany (82%), the ECDC data suggests, ”the newspaper said.

For its part France did not provide information to the European Center on the number of doses administered among the 1,137,600 received, but according to the Covidtracker.fr site “we estimate only 125,859 (11%)”.

“Today we believe that [la vacuna de AstraZeneca] it is almost ineffective for those over 65 ”, he declared a few weeks ago. Emmanuel Macron to reporters, saying there was “little information” about the drug. His statements have been criticized by various European leaders.

“The European Medicines Agency has approved the AstraZeneca vaccine for all age groups, but some national bodies have advised against its use in older age groups given the lack of available data on efficacy at the era, ”he explained. The Guardian.

AstraZeneca vaccine is widely used in Britain with one produced by Pfizer / BioNTech, showing high levels of efficacy in the elderly.

The Executive Director of the UK Medicines and Health Products Regulatory Agency, June Raine, defended his decision to approve the vaccine for all ages at this time, stressing that “current evidence suggests no lack of protection against Covid -19 in people aged 65” and that in this group it has generated “a strong immune response”

THE NATION

More information